Short and Efficient Chemoenzymatic Syntheses of non-Natural (−)-Muscarine and (+)-allo-Muscarine from Cyano-Sugar Precursors Catalyzed by Immobilized Burkholderia cepacia Lipase by Carnero Martín, Alejandro et al.
 1 
 FULL PAPER 
DOI: 10.1002/adsc.201600749 
Short and Efficient Chemoenzymatic Syntheses of non-Natural 
(−)-Muscarine and (+)-allo-Muscarine from Cyano-Sugar 
Precursors Catalyzed by Immobilized Burkholderia cepacia 
Lipase 
Alejandro Carnero,a Yogesh S. Sanghvi,b Vicente Gotor,a Susana Fernández,a* and 
Miguel Ferreroa* 
a Departamento de Química Orgánica e Inorgánica and Instituto Universitario de Biotecnología de Asturias, Universidad 
de Oviedo, Avenida Julián de Clavería 8, 33006-Oviedo (Asturias), Spain 
M.F.: tel. +34 985 105 013, mferrero@uniovi.es. S.F.: tel. +34 985 102 984, fernandezgsusana@uniovi.es; FAX (for 
both): +34 985 103 446 
b Rasayan Inc., 2802 Crystal Ridge Road, Encinitas, CA 92024-6615, USA 
Received: July 12, 2016; Revised: October 25, 2016; Published online: December 21, 2016 
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/adsc.201600749. 
Abstract. Enantiopure (2R)-configured non-natural (−)-
muscarine and (+)-allo-muscarine were efficiently 
synthesized by a chemoenzymatic approach from an easily 
accessible cyano-sugar available on large-scale. The key 
enzymatic hydrolysis step was accomplished by immobilized 
Burkholderia cepacia lipase (also known as Pseudomonas 
cepacia lipase, PSL-IM). The PSL-IM mediated 
regioselective hydrolysis of the 5-O-toluoyl ester group in 
cyano-sugars α− and β−, furnished 3-O-toluoyl-α-cyano-
sugar and 3-O-toluoyl-β-cyano-sugar, respectively, with 
total selectivity and in excellent yields. To demonstrate the  
industrial utility of this method, 3-O-toluoyl-β-cyano-sugar 
was synthesized on 10 g scale using PSL-IM and catalyst 
reused. A key feature of the synthesis route described 
herein is the simultaneous hydrogenolysis of a tosyl group, 
reduction of a nitrile and deprotection of a toluoyl group 
using LiAlH4 in one-pot procedure. This study offers green 
protocol for synthesis of two muscarine derivatives in high 
yields employing a concise four-step strategy. 
Keywords: biocatalysis; biotransformations; green 
chemistry; muscarine; synthesis design 
 
Introduction 
Functionalized tetrahydrofuran units are present in 
many naturally occurring molecules such as muscarin 
alkaloids.[1] The biological activity of these alkaloids 
have had remarkable influence on drug discovery 
efforts. Consequently, synthesis of muscarine 
derivatives have allured medicinal chemists for many 
years.[2] The toxic principle (+)-(2S,4R,5S)-muscarine 
(1, Figure 1) has generated much interest due to its 
potent and specific cholinergic activity.[3] 
Muscarine alkaloids were first isolated from 
Amanita muscaria, a mushroom found in 
pinewoods[4] and few species of toadstools, most 
stereoisomers of compound 1. Due to the three 
stereocenters in the molecule, eight stereoisomers are 
possible (Figure 1). Synthesis of all stereoisomers 2-8 
have been reported.[5] Preparation of muscarine 
homologues continue to generate excitement due to 
their high level of activity.[6] A renewed interest in 
this class of compounds is due to its selectivity 
towards muscarinic receptors in the brain and the 
discovery of its activity in the treatment of 
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Figure 1. List of natural and non-natural diastereoisomers 
of muscarine alkaloids. 
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neurodegenerative diseases such as Parkinson’s or 
Alzheimer’s diseases and other cognitive disorders.[7]  
Therefore, methods for selectively preparing 
enantiomerically pure muscarine alkaloids have 
received considerable attention. The published 
synthetic approaches are limited in versatility, 
specific for a single molecule, require multi-step 
synthesis and utilized expensive reagents and/or 
starting materials.[2,6a,8] The combination of growing 
demand and limited availability of muscarine 
derivatives from natural sources have led to syntheses 
from carbohydrate and non-carbohydrate starting 
materials. In view of this background and the 
biological relevance of muscarine alkaloids, herein 
we describe an efficient preparation of (−)-
muscarine[9] and (+)-allo-muscarine[9b,d,f,10] for which 
just a few synthesis are available. 
Results and Discussion 
For the preparation of muscarine analogs 2 and 4, we 
elected β-cyano-sugar 9 and α-cyano-sugar 19 as 
starting materials, respectively. The rationale behind 
the use of cyano-sugar is as follows: (i) cyano-sugar 
is easily synthesized from 2’-deoxyribose in few 
steps;[11] (ii) all chiral centers are predefined in 2-
deoxyribose; and (iii) cyano-sugar is commercially 
available on large-scale.[12] 
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Scheme 1. Attempted syntheses of (−)-muscarine 
hydroxide through a mesylate. Reaction conditions: (a) 
Lipase PSL-IM, 0.15 M KH2PO4 (pH 7), 1,4-dioxane, 45 
ºC, 14 h (94%); (b) MsCl, pyridine, DMAP, 0 °C to rt, 24 
h (88%); (c) LiAlH4, THF, reflux, 4 h; (d) NaBH4, 
NiCl2·6H2O, Boc2O, MeOH, 0 °C to rt, 16 h (55%). 
Based on our prior experience[13] with 
regioselective enzymatic hydrolysis, we envisioned 
that the removal of toluoyl attached to the primary 
hydroxyl group would set the stage for subsequent 
transformations leading to muscarine derivatives. In 
order to accomplish this feast, Candida antarctica 
lipase A, Candida antarctica lipase B, Pseudomonas 
cepacia lipase, †  Thermomyces lanuginosus lipase, 
and Pseudomonas fluorescens lipase were screened 
for selective hydrolysis. In the case of Candida 
antarctica lipase A and Candida antarctica lipase B, 
no reaction was observed. The other enzymes 
screened displayed total selectivity toward the 
hydrolysis of the ester at the C-5 position, but 
Pseudomonas cepacia lipase afforded the best 
hydrolysis rate in shortest reaction time. When 3,5-di-
O-p-toluoyl protected compound 9 was treated with 
the enzyme preparation PSL-SD (2:1 w/w relative to 
9) in 0.15 M phosphate buffer (pH 7) containing 18% 
of 1,4 dioxane at 30 ºC, 45 ºC, and 60 ºC, 1H-NMR 
spectra of the reaction mixture clearly indicated the 
formation of the 3-O-toluoyl ester 10 as the only 
product, due to selective hydrolysis of the 5-O-
toluoyl ester (Figure 2). The increase of the 
temperature from 30 ºC to 45 ºC reduced the reaction 
time. Thus, after 14 h at 45 ºC the starting material 
was consumed and 10 was isolated in 95% yield. 
 
Figure 2. Hydrolysis reaction of 9 with lipases at 
different temperatures: PSL-SD 30 ºC (●), PSL-SD 45 ºC 
(n), PSL-SD 60 ºC (p), PSL-IM 30 ºC (●), PSL-IM 45 ºC 
(n), and PSL-IM 60 ºC (p). 
Similarly, hydrolysis with immobilized 
Pseudomonas cepacia lipase (lipase PSL-IM) led 
exclusively to the formation of 10 in 24 h at 45 ºC 
with 94% isolated yield. We used the same ratio 2:1 
(w/w) of lipase, but since it is immobilized fewer 
units are needed per gram basis, hence the longer 
reaction time. It is noteworthy that the excellent 
                                                
† Note: Burkholderia cepacia is the most appropriate name, 
but most of the commercial suppliers use the old 
nomenclature Pseudomonas cepacia lipase or PSL-IM. 
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yields and purity of 10 were obtained without column 
chromatography. One advantage of the immobilized 
enzyme is the fact that it can be recycled to make the 
process more economical for industrial applications. 
The reaction of 10 with methanesulfonyl choride in 
pyridine and DMAP afforded mesylate 11 in 88% 
yield. Subsequent treatment with lithium aluminium 
hydride in THF at reflux enabled simultaneous 
hydrogenolysis, reduction and cleavage of the toluoyl 
group. However, the desired compound 12 was 
obtained as an inseparable mixture with 13 and 14. 
Formation of an alcohol (13) via S-O bond cleavage 
is often observed in the reduction of sulfonate esters, 
accounting for the low yields of desired product. It 
appears that the cyano group was reduced first, 
triggering the formation of a ring closed bicyclic 
structure 14. In order to circumvent the formation of 
compound 14, we opted for an alternate route where 
amino-group was protected with tert-
butyloxycarbonyl group. The one-pot synthesis of N-
Boc protected amine 15 was achieved by the reaction 
of 11 with di-tert-butyl dicarbonate and NiCl2·6H2O-
NaBH4 in MeOH (55% yield).[14] Treatment of 15 
with LiAlH4 at reflux furnished compounds 16 and 
17 as 2:1 mixture. These results prompted us to 
explore alternative synthetic strategy. 
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Scheme 2. Synthesis of (−)-muscarine hydroxide through a 
tosylate. Reaction conditions: (a) TsCl, pyridine, DMAP, 
0 °C to rt, 24 h (85%); (b) LiAlH4, THF, reflux, 4 h (84%); 
(c) i) MeI, 1,2,2,6,6-pentamethylpiperidine, EtOAc, 16 h, 
ii) NaOH 3 M (80%). 
Gratifyingly, the use of tosylate instead the 
mesylate avoided formation of a mixture of products 
while improving the yield. Thus, tosylate derivative 
18 was prepared from 10 in 85% yield by treatment 
with p-toluenesulfonyl chloride in pyridine and 
DMAP (Scheme 2). Next, compound 18 was treated 
with LiAlH4 in THF at reflux to afford exclusively 
the desired derivative 12 in 84% yield. It is 
noteworthy that a single reaction allowed complete 
transformation of three groups simultaneously in 
excellent yield. Finally, compound 12 was converted 
to (–)-muscarine by treatment with MeI and 1,2,2,6,6-
pentamethylpiperidine followed by ion-exchange 
with aqueous sodium hydroxide. 
 
Figure 3. Hydrolysis reaction of 19 at 45 ºC with lipase 
PSL-SD and lipase PSL-IM at different ratios of enzyme: 
PSL-SD 2:1 (n), PSL-IM 2:1 (●), PSL-IM 4:1 (p), and 
PSL-IM 6:1 (u). 
Next, the foregoing approach was utilized for the 
synthesis of (+)-allo-muscarine. Again the cyano-
sugar 19 was accessible on large-scale.[12] Selective 
deprotection of the primary toluoyl group was 
accomplished by reaction of 19 with lipase PSL-SD 
at 45 ºC in 0.15 M phosphate buffer (pH 7), 
furnishing 3-O-toluoyl derivative 20 after 4 d in 90% 
yield. The work up of this reaction was simplified, 
since compound 20 was obtained in high purity 
which enabled isolation without column 
chromatography (Figure 3). Under the same reaction 
conditions, total selectivity was also observed with 
lipase PSL-IM, but the reaction was slower and a 
maximum of 88% conversion was achieved after 7 d. 
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Scheme 3. Synthesis of (+)-allo-muscarine hydroxide 
Reaction conditions: (a) Lipase PSL-IM, 0.15 M KH2PO4 
(pH 7), 1,4-dioxane, 45 ºC, 5 d (90%); (b) TsCl, pyridine, 
DMAP, 0 °C to rt, 24 h (75%); (c) LiAlH4, THF, reflux, 4 
h (78%); (d) i) MeI, 1,2,2,6,6-pentamethylpiperidine, 
EtOAc, 16 h, ii) NaOH 3 M (76%). 
To overcome this limitation, we evaluated the 
influence on the conversion using different ratios of 
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enzyme. In this case, 4:1 and 6:1 (w/w) ratios of 
lipase:19 were employed. In 5 d transformation at 45 
ºC and 4:1 ratio of enzyme furnished 3-O-toluoyl 
derivative 20 with excellent regioselectivity and 
conversion. Subsequently, tosylation of 20 generated 
21 in 75% yield. Following same reaction conditions 
as in the case of 18, treatment of tosylate 21 with 
LiAlH4 resulted in the formation of the desired 
amino-alcohol 22 in a single step. Next, the amino 
group was quaternized to the corresponding (+)-allo-
muscarine hydroxide using previous conditions 
(Scheme 3). 
Scale-up studies. All of the above PSL-IM 
mediated hydrolysis experiments were carried out 
with 1:2 (w/w) enzyme ratio of 9:PSL-IM or 1:4 
(w/w) of 19:PSL-IM to drive the reaction to 
completion. In order to show the industrial utility of 
the process, we have scaled-up the enzymatic 
conversion of β-cyano sugar 9 to compound 10. The 
reaction was carried out with 10 g of 9 and reduced  
enzyme:substrate ratio of 1:1, making it cost-efficient. 
Thus, the reaction was complete in 24 h and work-up 
of the reaction provided crude 3-O-toluoylcyano 
sugar 10, which was isolated in 91% yield via 
precipitation. 
In order to reduce the cost of catalyst, we studied 
the possible reuse of immobilized lipase for multiple 
reactions (Table 1). Therefore, three sequential 
reactions were successfully carried out while 
maintaining same level of conversions and selectivity 
with a single lot of enzyme. During three reuse cycles  
same lot of enzyme was employed with 2 g of fresh 
substrate 9 or 19 in a substrate:enzyme ratio of 1:2 or 
1:4, respectively, in two separate experiments (entries 
1-3 and 4-6, Table 1). The reaction time for the third 
cycle was longer (entries 3 and 6, Table 1) perhaps 
due to loss of some immobilized enzyme. 
Table 1. Enzyme reuse during regioselective hydrolysis of 
α- or β-cyano derivatives with PSL-IM on 2 g scale at 45 
ºC. 
Entry Substrate Cycle t (h) Product Yield (%)a) 
1 9 1st 24 10 97 
2 9 2nd 24 10 98 
3 9 3rd 32 10 91 
4 19 1st 120 20 97 
5 19 2nd 120 20 89 
6 19 3rd 132 20 91 
a) Percentages of isolated yields of 3-O-toluoyl cyano-
sugars. 
Conclusion 
In summary, the chemoenzymatic strategy described 
herein provides an easy entry to non-natural 
muscarine derivatives using commercial biocatalysts, 
which have become an attractive and powerful tool in 
organic synthesis due to their high selectivity, mild 
reaction conditions and low environmental impact. 
The selective hydrolysis of toluoyl group with an 
enzyme provided much needed precision not 
available with traditional chemical approaches. The 
use of a predefined chiral auxillary permits rapid and 
affordable entry into the synthesis of modified 
muscarine analogs for discovery of potential 
therapeutics.[15] The key accomplishment of this route 
is the ability to synthesize two muscarine analogs in 
four easy steps and high overall yield. Yet another 
milestone of this route is the execution of three 
separate reactions in one-pot with a single reagent in 
high yield. The chemoenzymatic approach described 
herein was demonstrated on large-scale and 
constitutes a significant improvement over other 
methods reported in the literature for synthesis of 
non-natural muscarine. 
Experimental Section 
General 
General. Lipase PS “Amano SD” (24,700 u/g) is a crude 
enzyme preparation. Lipase PS “Amano IM” (816 u/g) is 
the lipase PS “Amano SD” immobilized on diatomaceous 
earth. Both were purchased from Amano Enzyme. All 
other reagents were bought from Aldrich at highest 
commercial quality and used without further purification. 
All non-aqueous reactions were carried out under 
anhydrous conditions in dry, freshly destilled solvents. 
Reactions were monitored by TLC carried out on 0.25 mm 
Merck silica gel plates (60F-254) using UV light as 
visualizing agent and/or acidic aqueous permanganate or 
3% of ninhydrin in ethanol. Flash chromatography was 
performed using silica gel 60 (230–400 mesh). Melting 
points were taken on samples in open capillary tubes and 
are uncorrected. 1H, 13C NMR, and DEPT were obtained 
using Bruker 300.13, 400.13 or 600.13 MHz for 1H, and 
75.5, 90.61 MHz or 150.90 for 13C. The same 
spectrometers were used for the acquisition of 1H-1H 
homonuclear (COSY and NOESY) and 1H-13C 
heteronuclear (HSQC and HMBC) correlations. Optical 
rotations were recorded on a Jasco P-1010 polarimeter and 
values are reported as follows: [α]λT (c: g/100 mL, solvent). 
High resolution mass spectra (HRMS) were recorded on a 
VG 7070 HS mass spectrometer under electron spray 
ionization (ESI) conditions. 
Note on compound naming: the numbering of the 
muscarine and derivatives is the same as usual of that 
muscarine analogs (see Figure 1), but note that all other 
compounds have different numbering, related with ribose 
derivatives, in order to simplify the names and make it 
clearer. 
(–)-Muscarine hydroxide (2).[16] 
1,2,2,6,6-Pentamethylpiperidine (94.7 mg, 0.61 mmol) and 
MeI (187 µL, 3 mmol) were added to a solution of 12 (40 
mg, 0.3 mmol) in EtOAc (1.3 mL). The reaction was 
stirred at rt during 16 h. The insoluble material was filtered 
and washed with EtOAc. The solid was poured in H2O and 
aqueous 3 M NaOH was added until basic pH. After being 
stirred 15-20 min, the water was evaporated and the 
residue was taken up in acetonitrile. The solid was filtered 
and the filtrate evaporated. The resulting solid was taken 
up in Et2O. The solid was filtered and washed with Et2O to 
afford 2 in 80% yield as a hygroscopic white solid. = 
−14.1 (c 1.0, EtOH); IR (KBr): ν 3424, 2970, 2919, 2850, 
1275 cm-1; 1H NMR (MeOH-d4, 300.13 MHz): δ 1.23 (d, 
3H, H6, J= 6.4 Hz), 1.92 (m, 1H, H3), 2.06 (ddd, 1H, H3, 
J= 13.2, 6.0, 2.5 Hz), 3.29 (s, 9H, NMe3), 3.51 (dd, 1H, H7, 
J= 13.6, 9.9 Hz), 3.74 (dd, 1H, H7, J= 13.6, 1.4 Hz), 3.97 
(m, 2H, H4+H5), 4.63 (q, 1H, H2, J= 9.7 Hz) ppm; 13C 
NMR (MeOH-d4, 75.5 MHz): δ 20.2 (C6), 39.6 (C3), 54.97, 
55.02, 55.07 (NMe3), 71.5 (C7), 73.1 (C2), 76.6 (C4), 85.3 
 5 
(C5) ppm; HRMS (ESI+, m/z):  calcd for C9H20NO2 
[(M+H)+]: 174.1488, found: 174.1488. 
(+)-allo-Muscarine hydroxide (4).[16] 
1,2,2,6,6-Pentamethylpiperidine (74.5 mg, 0.48 mmol) and 
MeI (149.4 µL, 2.4 mmol) were added to a solution of 22 
(32 mg, 0.24 mmol) in EtOAc (1.2 mL). The reaction was 
stirred at rt during 16 h. Next, solvent was evaporated and 
the insoluble material was washed with Et2O. The solid 
was poured in H2O and aqueous 3 M NaOH was added 
until basic pH. After being stirred 15-20 min, the water 
was evaporated and the residue was taken up in acetonitrile. 
The solid was filtered and the filtrate evaporated. The 
resulting solid was taken up in Et2O. The solid was filtered 
and washed with Et2O to afford 4 as a hygroscopic white 
solid in 76% yield. = +6.4 (c 1.0, EtOH); IR (KBr): ν 
3397, 2970, 2923, 1266 cm-1; 1H NMR (MeOH-d4, 300.13 
MHz): δ 1.19 (d, 3H, H6, J= 6.3 Hz), 1.64 (m, 1H, H3), 
2.53 (ddd, 1H, H3, J= 13.3, 7.9, 6.0 Hz), 3.24 (s, 9H, 
NMe3), 3.49 (dd, 1H, H7, J= 13.6, 1.7 Hz), 3.67 (dd, 1H, 
H7, J= 13.6, 10.0 Hz), 3.99 (m, 2H, H4+H5), 4.69 (m, 1H, 
H2) ppm; 13C NMR (MeOH-d4, 75.5 MHz): δ 19.0 (C6), 
39.2 (C3), 54.76, 54.81, 54.87 (NMe3) 71.2 (C7), 72.6 (C2), 
76.8 (C4), 83.4 (C5) ppm; HRMS (ESI+, m/z): calcd for 
C9H20NO2 [(M+H)+]: 174.1488, found: 174.1490. 
1β-Cyano-1,2-dideoxy-3-O-toluoyl-D-ribose (10). 
To a solution of 9 (2 g, 5.3 mmol) in 1,4-dioxane (9 mL) 
was added 0.15 M KH2PO4 pH 7 (44 mL) and lipase PSL-
IM (4 g). The mixture was allowed to react at 250 rpm and 
45 ºC during 24 h. The enzyme was filtered off and washed 
with CH2Cl2, the solvents were distilled, and the residue 
was taken up in NaHCO3 (aq) and extracted with CH2Cl2. 
The combined organic layers were dried over Na2SO4 and 
evaporated to give 10 in 94% yield as a white solid. Rf 
(30% EtOAc/Hexane): 0.29; Mp: 88−90 ºC; IR (KBr): ν 
3472, 2988, 2923, 2875, 1709, 1611, 1276, 1101 cm-1; 1H 
NMR (CDCl3, 300.13 MHz): δ 2.11 (br s, 1H, OH), 2.42 (s, 
3H, Me-Tol), 2.59 (ddd, 1H, H2, J= 13.8, 6.5, 1.8 Hz), 2.71 
(ddd, 1H, H2, J= 14.1, 9.3, 6.1 Hz), 3.87 (d, 2H, H5, J= 3.7 
Hz), 4.25 (q, 1H, H4, J= 3.6 Hz), 4.87 (dd, 1H, H1, J= 9.2, 
6.6 Hz), 5.52 (d, 1H, H3, J= 6.0 Hz), 7.25 (d, 2H, Horto-
Me, J= 7.8 Hz), 7.88 (d, 2H, Horto-CO, J= 8.2 Hz) ppm; 
13C NMR (CDCl3, 75.5 MHz): δ 21.8 (CH3), 38.3 (C2), 
62.6 (C5), 66.0 (C1), 75.7 (C3), 86.8 (C4), 118.3 (CN), 
126.5 (Cipso-CO), 129.4 (2CHarom), 129.8 (2CHarom), 
144.6 (Cipso-Me), 166.1 (C=O) ppm; HRMS (ESI+, m/z): 
calcd for C14H15NNaO4 [(M+Na)+]: 284.0893, found: 
284.0887. 
Scale-up protocol for compound 10. 
Similar procedure was followed, as described at small 
scale. Experiment was carried out with 10 g (26.5 mmol) 
of 9 dissolved in 45 mL of 1,4-dioxane, 220 mL of 0.15 M 
KH2PO4 pH 7 and 10 g of lipase PSL-IM. 
1β-Cyano-1,2-dideoxy-5-O-methanesulfonyl-3-O-
toluoyl-D-ribose (11). 
Methanesulfonyl chloride (92.9 µL, 1.18 mmol) and 
DMAP (10 mg) was added to a solution of 10 (140 mg, 
0.54 mmol) in anhydrous pyridine (1.1 mL) a 0 ºC. After 
being stirred at rt during 16 h, a new portion of MsCl (46 
µL, 0.59 mmol) was added and stirred continue until 24 h. 
Next, the mixture was taken up in chilled H2O and 
extracted with diethyl ether. The combined organic layers 
were dried over Na2SO4 and evaporated to give a residue, 
which was purified by column chromatography (30% 
EtOAc/hexanes) to give 11 in 88% yield as a white solid. 
Rf (30% EtOAc/Hexane): 0.19; Mp: 78−80 ºC; IR (KBr): ν 
3055, 2987, 2306, 1721, 1422, 1266 cm-1; 1H NMR 
(CDCl3, 300.13 MHz): δ 2.44 (s, 3H, Me-Tol), 2.69 (m, 2H, 
H2), 3.14 (s, 3H, Me-Ms), 4.45 (m, 2H, H4+ H5), 4.53 (dd, 
1H, H5, J= 11.9, 4.3 Hz), 4.92 (dd, 1H, H1, J= 8.6, 7.2 Hz), 
5.54 (m, 1H, H3), 7.27 (d, 2H, Horto-Me, J= 8.0 Hz), 7.90 
(d, 2H, Horto-CO, J= 8.2 Hz) ppm; 13C NMR (CDCl3, 75.5 
MHz): δ 21.8 (Me-Tol), 37.77 (C2), 37.81 (Me-Ms), 66.3 
(C1), 68.3 (C5), 75.1 (C3), 83.7 (C4), 117.8 (CN), 126.1 
(Cipso-CO), 129.4 (2CHarom), 129.8 (2CHarom), 144.9 
(Cipso-Me), 165.9 (C=O) ppm; HRMS (ESI+, m/z): calcd 
for C15H17NNaO6S [(M+Na)+]: 362.0669, found: 362.0664. 
1β-Aminomethyl-1,2,5-trideoxy-D-ribose (12). 
From 18. LiAlH4 (132 mg, 3.47 mmol) was added to a 
solution of 18 (180 mg, 0.43 mmol) in anhydrous THF (2.8 
mL). The reaction was stirred at reflux during 4 h. Excess 
of the reagent was decomposed by addition of EtOAc (8 
mL) and MeOH (8 mL). The solvents were evaporated and 
the crude product was subjected to column 
chromatography (MeOH) affording 12 in 84% yield as a 
slightly yellowish viscous liquid. Rf (1% NH3/MeOH): 
0.35; IR (KBr): ν 3383, 3054, 2985, 1265 cm-1; 1H NMR 
(MeOH-d4, 300.13 MHz): δ 1.20 (d, 3H, Me, J= 6.4 Hz), 
1.86 (dd, 2H, H2, J= 7.4, 4.7 Hz), 2.64 (dd, 1H, H6, J= 13.2, 
6.7 Hz), 2.76 (dd, 1H, H6, J= 13.1, 4.1 Hz), 3.80 (m, 1H, 
H4), 3.89 (q, 1H, H3, J= 4.9 Hz), 4.10 (m, 1H, H1) ppm; 13C NMR (MeOH-d4, 75.5 MHz): δ 19.9 (CH3), 38.4 (C2), 
47.0 (C6), 78.1 (C3), 80.1 (C1), 83.6 (C4) ppm; HRMS 
(ESI+, m/z): calcd for C6H14NO2 [(M+H)+]: 132.1019, 
found: 132.1023. 
Mixture of compounds 12, 13, and 14. 
From 11. LiAlH4 (30.4 mg, 0.8 mmol) was added to a 
solution of 11 (35 mg, 0.1 mmol) in anhydrous THF (0.7 
mL). The reaction was stirred at reflux during 4 h. Excess 
of the reagent was decomposed by addition of EtOAc (2 
mL) and MeOH (2 mL). The solvents were evaporated and 
the crude product was subjected to column 
chromatography (MeOH) affording 12 and 14 as a mixture, 
and 13. 
1β-Aminomethyl-1,2-dideoxy-D-ribose (13). 
Yellowish oil. Rf (1% NH3/MeOH): 0.25; IR (NaCl): ν 
3420, 2953, 1644 cm-1; 1H NMR (MeOH-d4, 300.13 MHz): 
δ 1.88 (m, 2H, H2), 2.74 (dd, 1H, H6, J= 13.2, 6.9 Hz), 
2.92 (dd, 1H, H6, J= 13.2, 3.5 Hz), 3.53 (dd, 1H, H5, J= 
11.7, 5.0 Hz), 3.61 (dd, 1H, H5, J= 11.7, 4.1 Hz), 3.81 (q, 
1H, H4, J= 4.4 Hz), 4.10 (m, 2H, H1+ H3) ppm; 13C NMR 
(MeOH-d4, 75.5 MHz): δ 38.9 (C2), 45.9 (C6), 63.8 (C5), 
73.9 (C3), 79.1 (C1), 88.8 (C4) ppm; HRMS (ESI+, m/z): 
cald for C6H14NO3 [(M+H)+]: 148.0968, found: 148.0974. 
Selected signals for compound 14 from the mixture 
of 12 and 14. Yellowish oil. Rf (1% NH3/MeOH): 0.38; 1H 
NMR (MeOH-d4, 300.13 MHz): δ 1.89 (overlapped, 1H, 
H2), 2.38 (dd, 1H, H2, J= 13.5, 7.4 Hz), 2.50–3.10 (several 
signals, 2H5 + 2H6), 3.91, 4.39, 4.51 (H1, H3, H4) ppm; 
HRMS (ESI+, m/z): calcd for C6H12NO2 [(M+H)+]: 
130.0862, found: 130.0862. 
1β-N-(tert-Butyloxycarbonyl)aminomethyl-1,2-dideoxy-
5-O-methanesulfonyl-3-O-toluoyl-D-ribose (15). 
NiCl2·6H2O (5,7 mg, 0.024 mmol) and di-tert-
butyldicarbonate (104.7 mg, 0.48 mmol) were added to a 
solution of 11 (80 mg, 0.24 mmol) in anhydrous MeOH 
(1.8 mL). Next, the mixture was cooled to 0 ºC and NaBH4 
(63.6 mg, 1.68 mmol) was added in small portions over 15 
min. The reaction is allowed to reach room temperature in 
the bath and stirred overnight. Then, the mixture was 
filtered over celite®, the solvent evaporated and the crude 
product purified by column chromatography (30% 
EtOAc/hexanes) affording 15 in 55% yield as a white solid. 
Rf (30% EtOAc/Hexane): 0.35; 1H NMR (MeOH-d4, 
300.13 MHz): δ 1.45 (s, 9H, Me-Boc), 2.00 (m, 1H, H2), 
2.16 (m, 1H, H2), 2.41 (s, 3H, Me-Tol), 3.15 (s, 3H, Me-
Ms), 3.32 (m, 2H, H6 overlapped with MeOH-d4), 4.26 (m, 
2H, H1+H4), 4.41 (d, 2H, H5, J= 3.9 Hz), 5.36 (d, 1H, H3, 
J= 6.4 Hz), 7.30 (d, 2H, Horto-Me, J= 8.2 Hz), 7.91 (d, 2H, 
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Horto-CO, J= 8.2 Hz) ppm; 13C NMR (MeOH-d4, 75.5 
MHz): δ 21.7 (Me-Tol), 28.7 (3Me-Boc), 36.4 (C2), 37.5 
(Me-Ms), 44.4 (C6), 70.9 (C5), 77.8 (C3), 79.9 (C1), 80.3 
(C-tBu), 83.9 (C4), 128.2 (Cipso-CO), 130.3 (2CHarom), 
130.7 (2CHarom), 145.6 (Cipso-Me), 158.5 (NH-C=O), 
167.6 (O-C=O) ppm. 
1β-N-(Methyl)aminomethyl-1,2,5-trideoxy-D-ribose 
(16) and 1β-N-(Methyl)aminomethyl-1,2-dideoxy-D-
ribose (17). 
LiAlH4 (30.4 mg, 0.8 mmol) was added to a solution of 15 
(45 mg, 0.1 mmol) in anhydrous THF (0.7 mL). The 
reaction was stirred at reflux during 4 h. Excess of the 
reagent was decomposed by addition of EtOAc (2 mL) and 
MeOH (2 mL). The solvents were evaporated and the 
crude product was subjected to column chromatography 
(MeOH) affording 16 and 17. 
1β-N-(Methyl)aminomethyl-1,2,5-trideoxy-D-ribose 
(16). Oil. Rf (1% NH3/MeOH): 0.25; IR (NaCl): ν 3570, 
3505, 2979, 2864, 1069 cm-1; 1H NMR (MeOH-d4, 300.13 
MHz): δ 1.21 (d, 3H, H5, J= 6.2 Hz), 1.89 (m, 1H, H2), 
1.98 (ddd, 1H, H2, J= 13.2, 6.4, 3.1 Hz), 2.60 (s, 3H, Me-
NH), 2.81 (dd, 1H, H6, J= 12.5, 8.7 Hz), 3.02 (dd, 1H, H6, 
J= 12.5, 3.1 Hz), 3.84 (m, 1H, H4), 3.93 (m, 1H, H3), 4.32 
(m, 1H, H1) ppm; 13C NMR (MeOH-d4, 75.5 MHz): δ 19.9 
(C5), 34.7 (Me-NH), 39.0 (C2), 55.6 (C6), 75.5 (C1), 77.8 
(C3), 84.2 (C4) ppm; HRMS (ESI+, m/z): calcd for 
C7H16NO2 [(M+H)+]: 146.1176, found: 146.1176. 
1β-N-(Methyl)aminomethyl-1,2-dideoxy-D-ribose 
(17). Yellowish oil. Rf (2% NH3/MeOH): 0.21; 1H NMR 
(MeOH-d4, 300.13 MHz): δ 1.85 (m, 1H, H2), 1.98 (ddd, 
1H, H2, J= 13.1, 6.1, 2.5 Hz), 2.62 (s, 3H, Me-NH), 2.89 
(dd, 1H, H6, J= 12.5, 8.5 Hz), 3.05 (dd, 1H, H6, J= 12.5, 
3.0 Hz), 3.54 (dd, 1H, H5, J= 11.8, 4.9 Hz), 3.62 (dd, 1H, 
H5, J= 11.8, 4.9 Hz), 3.84 (q, 1H, H4, J= 4.3 Hz), 4.24 and 
4.38 (2m, 2H, H1, H3) ppm. 
1β-Cyano-1,2-dideoxy-5-O-toluenesulfonyl-3-O-toluoyl-
D-ribose (18). 
p-Toluenesulfonyl chloride (335 mg, 1.76 mmol) and 
DMAP (10 mg) was added to a solution of 10 (210 mg, 0.8 
mmol) in anhydrous pyridine (1.6 mL) a 0 ºC. After being 
stirred at rt during 16 h, a fresh portion of p-TsCl (167 mg, 
0.88 mmol) was added and stirred continue until 24 h. 
Next, the mixture was taken up in chilled H2O and 
extracted with diethyl ether. The combined organic layers 
were dried over Na2SO4 and evaporated to give a residue, 
which was purified by column chromatography (30% 
EtOAc/hexanes) to give 18 in 85% yield as a white solid. 
Rf (30% EtOAc/Hexane): 0.35; Mp: 132–134 ºC; IR 
(KBr): ν 3038, 2951, 2925, 2253, 1715, 1611, 1338, 1271, 
1185 cm-1; 1H NMR (CDCl3, 300.13 MHz): δ 2.42 (s, 3H, 
Me-Tol), 2.45 (s, 3H, Me-Ts), 2.60 (m, 2H, H2), 4.14 (m, 
1H, H5), 4.35 (m, 2H, H4+ H5), 4.80 (dd, 1H, H1, J= 8.9, 
7.1 Hz), 5.46 (m, 1H, H3), 7.25 (d, 2H, Horto-Me-Tol, J= 
8.7 Hz), 7.37 (d, 2H, Horto-Me-Ts, J= 8.1 Hz), 7.85 (2d, 
4H, Harom) ppm; 13C NMR (CDCl3, 75.5 MHz): δ 21.8 
(CH3), 21.9 (CH3), 37.79 (C2), 66.1 (C1), 68.6 (C5), 75.3 
(C3), 83.6 (C4), 117.5 (CN), 126.1 (Cipso-CO), 128.2 
(2CHarom), 129.4 (2CHarom), 129.8 (2CHarom), 130.2 
(2CHarom), 132.2 (Cipso-SO3), 144.8 (Cipso-Me-Tol), 
145.5 (Cipso-Me-Ts), 165.9 (C=O) ppm; HRMS (ESI+, 
m/z): calcd for C21H21NNaO6S [(M+Na)+]: 438.0982, 
found: 438.0980. 
1α-Cyano-1,2-dideoxy-3-O-toluoyl-D-ribose (20). 
Similar procedure as that described for 10 starting from 19 
using lipase PSL-IM [4:1 (w/w), ratio of lipase:19] yielded 
20 (90%) after 5 d. The Erlenmeyer flask containing 19 
and 1,4-dioxane was heated previously in an orbital shaker 
at 60 ºC during 5-10 min to improve the solubility of 
starting material. Yield a white solid. Rf (30% 
EtOAc/Hexane): 0.13; Mp: 90−92 ºC; IR (KBr): ν 3489, 
3466, 3414, 2973, 2923, 2882, 2237, 1712, 1611, 1271, 
1096 cm-1; 1H NMR (CDCl3, 300.13 MHz): δ 2.07 (s, 1H, 
OH), 2.43 (s, 3H, Me-Tol), 2.56 (d, 1H, H2, J= 14.1 Hz), 
2.68 (ddd, 1H, H2, J= 14.2, 8.0, 6.3 Hz), 3.88 (d, 2H, H5, 
J= 3.4 Hz), 4.41 (m, 1H, H4), 5.05 (d, 1H, H1, J= 7.0 Hz), 
5.54 (d, 1H, H3, J= 6.1 Hz), 7.28 (d, 2H, Horto-Me, J= 8.1 
Hz), 8.00 (d, 2H, Horto-CO, J= 8.1 Hz) ppm; 13C NMR 
(CDCl3, 75.5 MHz): δ 21.8 (CH3), 38.3 (C2), 62.5 (C5), 
66.7 (C1), 75.1 (C3), 87.0 (C4), 118.7 (CN), 126.5 (Cipso-
CO), 129.4 (2CHarom), 130.0 (2CHarom), 144.6 (Cipso-
Me), 166.5 (C=O) ppm; HRMS (ESI+, m/z): calcd for 
C14H15NNaO4 [(M+Na)+]: 284.0893, found: 284.0882. 
General Protocol for Enzyme Reuse. 
Similar procedure as that described for the preparation of 
β-10 is followed except that after enzyme filtration, it was 
washed with 1,4-dioxane and dried under vacuum. No 
further manipulation was necessary to use the enzyme for 
the next run. 
1α-Cyano-1,2-dideoxy-5-O-toluenesulfonyl-3-O-toluoyl-
D-ribose (21). 
Similar procedure as that described for 18 starting from 20 
yielded 21 (75%) as a white solid. Rf (30% 
EtOAc/Hexane): 0.26; Mp: 156−158 ºC; IR (KBr): ν 2970, 
2922, 2238, 1716, 1613, 1342, 1286, 1170 cm-1; 1H NMR 
(CDCl3, 300.13 MHz): δ 2.40 (s, 3H, Me-Tol), 2.45 (s, 3H, 
Me-Ts), 2.52 (d, 1H, H2, J= 14.2 Hz), 2.61 (m, 1H, H2), 
4.25 (dd, 1H, H5, J= 11.1, 2.8 Hz), 4.33 (dd, 1H, H5, J= 
11.1, 2.7 Hz), 4.44 (m, 1H, H4), 4.93 (dd, 1H, H1, J= 8.0, 
1.3 Hz), 5.44 (d, 1H, H3, J= 5.9 Hz), 7.25 (d, 2H, Horto-
Me-Tol, J= 7.8 Hz), 7.36 (d, 2H, Horto-Me-Ts, J= 8.2 Hz), 
7.79 (d, 2H, Horto-SO3-Ts, J= 8.3 Hz), 7.95 (d, 2H, Horto-
CO-Tol, J= 8.2 Hz) ppm; 13C NMR (CDCl3, 75.5 MHz): δ 
21.8 (CH3), 21.9 (CH3), 37.9 (C2), 66.9 (C1), 69.0 (C5), 
74.9 (C3), 84.1 (C4), 118.4 (CN), 126.2 (Cipso-CO), 128.1 
(2CHarom), 129.5 (2CHarom), 130.1 (2CHarom), 130.2 
(2CHarom), 132.3 (Cipso-SO3), 144.7 (Cipso-Me-Tol), 
145.5 (Cipso-Me-Ts), 166.2 (C=O) ppm; HRMS (ESI+, 
m/z): calcd for C21H21NNaO6S [(M+Na)+]: 438.0982, 
found: 438.0982. 
1α-Aminomethyl-1,2,5-trideoxy-D-ribose (22). 
Similar procedure as that described for 12 starting from 21 
yielded 22 (78%) as a slightly yellowish viscous liquid. Rf 
(1% NH3/MeOH): 0.28; IR (NaCl): ν 3375, 3054, 2972, 
2931, 1266 cm-1; 1H NMR (MeOH-d4, 300.13 MHz): δ 
1.16 (d, 3H, Me, J= 6.2 Hz), 1.60 (dt, 1H, H2, J= 13.0, 5.7 
Hz), 2.43 (m, 1H, H2), 2.74 (d, 2H, H6, J= 5.2 Hz), 3.89 (m, 
2H, H3+H4), 4.11 (m, 1H, H1) ppm; 13C NMR (MeOH-d4, 
75.5 MHz): δ 18.9 (CH3), 38.1 (C2), 46.7 (C6), 77.7 (C1), 
79.1, 82.4 (C3+C4) ppm; HRMS (ESI+, m/z): calcd for 
C6H14NO2 [(M+H)+]: 132.1019, found 132.1017. 
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